key: cord-1042297-dwkxtvuy
authors: Dubey, Abhishek; Kotnala, Garima; Mandal, Tuhin K.; Sonkar, Subash C.; Singh, Vijay K.; Guru, Sameer A.; Bansal, Aastha; Irungbam, Monica; Husain, Farah; Goswami, Binita; Kotnala, Ravindra K.; Saxena, Sonal; Sharma, Sudhir K.; Saxena, Kirti N.; Sharma, Chhemendra; Kumar, Suresh; Aswal, Dinesh K.; Manchanda, Vikas; Koner, Bidhan C.
title: Evidence of the presence of SARS‐CoV‐2 virus in atmospheric air and surfaces of a dedicated COVID hospital
date: 2021-05-03
journal: J Med Virol
DOI: 10.1002/jmv.27029
sha: 40f320d7b5211228d880d73d9d30926a82e70aae
doc_id: 1042297
cord_uid: dwkxtvuy

The present study was conducted from July 1, 2020 to September 25, 2020 in a dedicated coronavirus disease 2019 (COVID‐19) hospital in Delhi, India to provide evidence for the presence of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) virus in atmospheric air and surfaces of the hospital wards. Swabs from hospital surfaces (patient's bed, ward floor, and nursing stations area) and suspended particulate matter in ambient air were collected by a portable air sampler from the medicine ward, intensive care unit, and emergency ward admitting COVID‐19 patients. By performing reverse‐transcriptase polymerase chain reaction (RT‐PCR) for E‐gene and RdRp gene, SARS‐CoV‐2 virus was detected from hospital surfaces and particulate matters from the ambient air of various wards collected at 1 and 3‐m distance from active COVID‐19 patients. The presence of the virus in the air beyond a 1‐m distance from the patients and surfaces of the hospital indicates that the SARS‐CoV‐2 virus has the potential to be transmitted by airborne and surface routes from COVID‐19 patients to health‐care workers working in COVID‐19 dedicated hospital. This warrants that precautions against airborne and surface transmission of COVID‐19 in the community should be taken when markets, industries, educational institutions, and so on, reopen for normal activities.

Since the outbreak of coronavirus disease-19 in Wuhan, China, humanity has been continuously engaged in a fight for controlling this pandemic. It is evident that we have become better at controlling the pandemic compared with previous pandemics. This is attributed to technological advancements. It took only about 2 weeks to identify and publish the gene sequence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative coronavirus for COVID-19, and also to develop a diagnostic method for its detection using the reversetranscriptase polymerase chain reaction (RT-PCR). [1] [2] [3] [4] In addition, unprecedented progress has been made in other aspects of the disease. The roles of Angiotensinogen Converting Enzyme-2 (ACE-2) receptors and other molecules, cytokine storm, and coagulation dysregulation in its pathogenesis are established. [5] [6] [7] Serosurveillance by immunoassay of antibodies has been developed. [8] [9] [10] Many drug trials have been carried out that established the role of dexamethasone, anti-retroviral agents, hydroxychloroquine (HCQ), ivermectin, tocilizumab, curcumin, and so on, in the treatment of COVID-19 with some degree of success. [11] [12] [13] [14] [15] [16] [17] Scientists have developed various vaccines against COVID-19 and these are under evaluation. [18] [19] [20] [21] However, we do not have clear knowledge about the routes followed by the virus during transmission from one individual to others. 22, 23 As of now, the general notion is that the virus gets transmitted either through droplets or through direct contact with an infected person or by touching the surfaces/ fomites where an infected person has shed the virus. [22] [23] [24] [25] [26] [27] [28] [29] [30] The virus enters the human body through the nose, mouth, or eyes. However, whether the virus spreads through air is far from clear, although some reports are present, which have suggested considering airborne precautions. 22, 23 At a virtual workshop entitled "Airborne Transmission of SARS-CoV-2" conducted by the National Academies of Science, Engineering, and Medicine, various field experts reviewed the available data related to transmission routes of the virus along with its historical context. 31 The evidence for airborne transmission of SARS-CoV-2 is admittedly incomplete. They also stated that the evidence for it not being airborne is also incomplete. The evidence for transmission of this virus through air remains inconclusive. It is therefore imperative to address this issue and provide evidence of its being air-borne if it is so.

In India, the index case was detected in Thrissur, Kerala on January 30, 2020 and by the end of October 2020, the total number of confirmed cases crossed 81 million. 32 Despite the best precautions, many health-care workers working in these hospitals got infected and a few of them died. [33] [34] [35] Air-borne transmission or transmission by touching surfaces is suspected in the transmission of COVID-19 in the hospital set up. [36] [37] [38] Hence, this study was conducted to collect the data from this COVID-19 dedicated hospital to find out whether the SARS- 

It was an in vitro study.

Written informed consent was obtained from the participants ≥18 years of age before they were recruited for the study. Similarly, on 6 different days, six different patients suffering from RT-PCR confirmed COVID-19 with severe illness requiring admission to ICU within the last 48 h for high flow oxygen therapy or invasive ventilator support were selected randomly among the COVID-19 patients admitted to ICU. As these patients were very sick and on noninvasive or invasive ventilator support to perform the above-mentioned activity, it was not checked if they were active cases or not. In the emergency ward, the COVID-19 patients were getting clinically evaluated, receiving immediate management, and were sent to either the medicine ward or ICU depending on the treatment need. So the patients were in transit and were staying for few minutes to few hours in the emergency ward.

Whether these cases were active or not was not checked when particulate matter from the air was collected from the emergency ward. Particulate matters from the ambient air of the medicine ward were collected by using the above-mentioned air sampler keeping it at a distance of 3 m from the head end of the selected active COVID cases. Then the process was repeated by keeping the air sampler at 1-m distance from the selected patients. The air sampler was placed on a table to cover up the height of the patients' bed.

From ICU, suspended particulate matters were collected similarly by keeping the air sampler at 1-and 3-m distance from the selected cases who were on noninvasive ventilator support.

In the emergency ward, particulate matter from the air was collected by keeping the air sampler at the center of the ward. The TSP samples were collected for a 1-h period at every instance.

After a collection period of 1 h, PVDF membranes were removed from the air sampler, placed with forceps into 15 ml centrifuge tubes containing 5 ml VTM and sent similarly for RT-PCR. 

Collection of particulate matter from the air was carried out on 6 different days using different patients and similarly, swabs were collected from surfaces on three different occasions. Quantitative data (C t value) was presented as mean and standard deviation.

Qualitative data (+ve RT-PCR) were presented as a percentage.

C t values were compared by unpaired t test or one-way analysis of variance followed by Tukey's post hoc test. Ap < .05 was considered statistically significant.

As shown in Table 2 , the RNAs of SARS-CoV-2 were detected in atmospheric air at a distance of 1 and 3 m from the active COVID-19 patients of the medicine ward and ICU and as well as in the emergency ward of the dedicated COVID-19 hospital. RT-PCR positivity rate was higher when particulate matter was collected at a 1-m distance than that collected at a 3-m distance from COVID-19 patients. (Table 3 ). ward area ratio in the ICU were always lower than that in the medicine ward.

The air in the emergency ward was also found to be contaminated with SARS-CoV-2 virus (Table 2) . Athough the patients stay here for very short duration, yet the viral load in air was similar to that in atmospheric air of ICU and medicine ward (as found at 3-m distance from the patients). Hence, we presume that chance of acquiring COVID-19 by air-borne route from the emergency ward is not less than that of ICU and medicine ward.

Work stations in medicine ward and ICU had a glass separation from the area where patients were admitted and in the air of those work station areas, SARS-CoV-2 RNA was not detected (Table 4 ). Therefore, airborne transmission of COVID-19 is not probable from these walled nursing work-station areas. But in the emergency ward, the workstation did not have any wall or glass barrier to keep it separate from the environment where patients were admitted. Hence, the chance of air-borne transmission for health-care workers from work-station at emergency ward might be present.

Patients' bed and floor of the wards but not the tables in the work stations of nurses in medicine ward and ICU were found to

The details of the target genes and their primers, probes, and sequences used for detection of the SARS-CoV-2 virus 22 So, we surmise that hospital-acquired COVID-19 infection by health-care workers may occur through these contaminated surfaces.

As shown in Figure 2 , it was found that chance of detecting SARS-CoV-2 viral RNA is less when flow rate of air sampler is fixed at 1. 

The infrastructure of multidisciplinary research unit (MRU) at Maulana

A novel coronavirus from patients with pneumonia in China

Molecular diagnostic technologies for COVID-19: limitations and challenges

Clinical characteristic and epidemiological features of SARS CoV-2 disease patients from a COVID-19 designated hospital in New Delhi

An update on molecular diagnostics for COVID-19

Pathophysiology, tansmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review

Bar diagram showing mean and standard deviation (SD) of cycle threshold (C t ) values of RT-PCR test for E-gene and RdRp gene of SARS-CoV-2 virus conducted with particulate matter obtained from air of different wards admitting COVID-19 patients when the flow rate of air sampler was adjusted to 1.5, 16.7, and 27 liter per minute (LPM). Mean and SD were calculated from the samples those were positive for both E-gene and RdRp gene irrespective of distance from the patient at which the air sampler was placed

reverse-transcriptase polymerase chain reaction; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2

An update on COVID-19 pandemic: the epidemiology, pathogenesis, prevention and treatment strategies

Pathogenesis, clinical manifestations and complications of coronavirus disease

COVID-19 serology at population scale: SARS-CoV-2-specific antibody responses in saliva

COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics

Development and performance evaluation of a rapid in-house ELISA for retrospective serosurveillance of SARS-CoV-2

World Health Organization. Coronavirus disease (COVID-19): Dexamethasone. WHO

Efficacy of dexamethasone treatment for patients with the acute respiratory distress syndrome caused by COVID-19: study protocol for a randomized controlled superiority trial

Insights into antiviral mechanisms of remdesivir, lopinavir/ritonavir and chloroquine/hydroxychloroquine affecting the new SARS-CoV-2

Hydroxychloroquine in patients with COVID-19: A Systematic Review and meta-analysis

Ivermectin: a systematic review from antiviral effects to COVID-19 complementary regimen

Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality

Curcumin, a traditional spice component, can hold the promise against COVID-19?

Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine

A Thermostable mRNA vaccine against COVID-19

Viral targets for vaccines against COVID-19

A review of the progress and challenges of developing a vaccine for COVID-19

WHO.Coronavirus Disease (COVID-19): How Is It Transmitted

World Health Organization.Transmission of SARS-CoV-2: Implications for Infection Prevention Precautions. Scientific brief

Turbulent gas clouds and respiratory pathogen emissions: potential implications for reducing transmission of COVID-19

Droplet fate in indoor environments, or can we prevent the spread of infection? In: Indoor Air

Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patient

Detection of air and surface contamination by SARS-CoV-2 in hospital rooms of infected patients

Aerodynamic analysis of SARS-CoV-2 in two Wuhan hospitals

Aerosol and surface distribution of severe acute respiratory syndrome coronavirus 2 in hospital wards

National Academies of Sciences, Engineering and M. Virtual Workshop on Airborne Transmission of SARS-CoV-2. APIC,2020

India's first coronavirus infection confirmed in Kerala. The Hindu

Healthcare worker infections and deaths due to COVID-19: a survey from 37 nations and a call for WHO to post national data on their website

In-house assembled protective devices in laboratory safety against SARS-nCoV-2 in clinical biochemistry laboratory of a COVID dedicated hospital

Covid-19 related deaths among doctors in India

How can airborne transmission of COVID-19 indoors be minimised?

Aerosols, droplets, and airborne spread: everything you could possibly want to know; 2020. FIRST10EM.first10em. com/aerosols-droplets-and-airborne-spread

Environmental contamination by SARS-CoV-2 in a designated hospital for coronavirus disease 2019

STANDARD M NCoV Real-Time Detection Kit Instructions for Use

SARS-CoV-2 and health care worker protection in low-risk settings: a review of modes of transmission and a novel airborne model involving inhlable particles